Vaxart (VXRT) Common Equity (2010 - 2026)
Vaxart's Common Equity came in at $82.37 million for Q2 2026, up 150.5% from $32.88 million a year earlier but down 12.5% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Vaxart's Common Equity was $87.8 million, up 49.0% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
- Going back by year, Common Equity was $58.93 million in FY2024 (+1.9%), $57.81 million in FY2023 (-47.7%), $110.6 million in FY2022 (-41.0%) and $187.53 million in FY2021 (+52.0%).
- The five-year range for quarterly Common Equity is $26.76 million (Q3 2025) to $204.95 million (Q3 2021).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 20.7% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 150.5%), and the weakest in Q3 2025 (a decline of 60.9%).
- Business Quant data shows VXRT's Common Equity at $94.12 million (Q1 2026), $87.8 million (Q4 2025) and $26.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Vaxart | 115.76 Mn | 51.76 Mn | - | 82.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.37 Mn |
| Mar 31, 2026 | 94.12 Mn |
| Dec 31, 2025 | 87.80 Mn |
| Sep 30, 2025 | 26.76 Mn |
| Jun 30, 2025 | 32.88 Mn |
| Mar 31, 2025 | 45.62 Mn |
| Dec 31, 2024 | 58.93 Mn |
| Sep 30, 2024 | 68.44 Mn |
| Jun 30, 2024 | 80.01 Mn |
| Mar 31, 2024 | 55.69 Mn |
| Dec 31, 2023 | 57.81 Mn |
| Sep 30, 2023 | 71.52 Mn |
| Jun 30, 2023 | 85.07 Mn |
| Mar 31, 2023 | 89.75 Mn |
| Dec 31, 2022 | 110.60 Mn |
| Sep 30, 2022 | 122.31 Mn |
| Jun 30, 2022 | 143.09 Mn |
| Mar 31, 2022 | 166.37 Mn |
| Dec 31, 2021 | 187.53 Mn |
| Sep 30, 2021 | 204.95 Mn |
API Access
Vaxart Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();